Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome

Rheumatology

Volumn 45, Issue 7, 2006, Pages 833-841

  Blank, M ^a   Krause, I ^a,b   Magrini, L ^a   Spina, G ^c,d   Kalil, J ^c,d   Jacobsen, S ^e   Thiesen, H J ^f   Cunningham, M W ^g   Guilherme, L ^c,d   Shoenfeld, Y ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Millennium Institute   (Brazil)

^e HVIDOVRE HOSPITAL   (Denmark)

^f UNIVERSITY OF ROSTOCK   (Germany)

^g UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Anti 2GPI Abs; Anti M protein Abs; Carditis; Chorea; Streptococcal infection

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; ENZYME ANTIBODY; EPITOPE; IMMUNOGLOBULIN G; M PROTEIN; N ACETYL BETA GLUCOSAMINIDASE; PEPTIDE ANTIBODY; PROTEIN ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; CHOREA; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DISEASE; HUMAN; HUMORAL IMMUNITY; HYPOTHESIS; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PATHOGENESIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RHEUMATIC FEVER; SOLID PHASE SYNTHESIS; VALVULAR HEART DISEASE;

ACETYLGLUCOSAMINE; ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BACTERIAL OUTER MEMBRANE PROTEINS; BETA 2-GLYCOPROTEIN I; BINDING, COMPETITIVE; BLOTTING, WESTERN; CARRIER PROTEINS; CROSS REACTIONS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; RHEUMATIC FEVER;

EID: 33745632627     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel118     Document Type: Article

References (67)

1. Guilherme L, Kalil J. Rheumatic fever: From sore throat to autoimmune heart lesions. Int Arch Allergy Immunol 2004;134:56-64.
2. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992;268:2069-73.
3. Sargent SJ, Beachey EH, Corbett CE, Dale JB. Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes. J Immunol 1987;139:1285-90.
4. Dale JB, Beachey EH. Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med 1985;161:113-22.
5. Cunningham MW. Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease. Front Biosci 2003; 8:s533-43.
6. Fenderson PG, Fischetti VA, Cunningham MW. Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol 1989;142:2475-81.
7. Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985;162:583-91.
8. Krisher K, Cunningham MW. Myosin: A link between streptococci and heart. Science 1985;227:413-5.
9. Shikhman AR, Greenspan NS, Cunningham MW. A subset of mouse monoclonal antibodies cross-reactive with cytoskeletal proteins and group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamine. J Immunol 1993;151:3902-13.
10. Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 2000;106:217-24.
11. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003;9:914-20.
12. Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 1989; 143:2677-83.
13. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63.
14. Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus 2003; 12:497-8.
15. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46:1019-27.
16. Cervera R, Khamashta MA, Font J et al. High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome. Lupus 1991;1:43-7.
17. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996;93:1579-87.
18. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924;33:701-37.
19. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486-9.
20. Schwarzenbacher R, Zeth K, Diederichs K et al. Crystal structure of human beta2-glycoprotein I: Implications for phospholipid binding and the antiphospholipid syndrome. Embo J 1999;18:6228-39.
21. Bouma B, de Groot PG, van den Elsen JM et al. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J 1999;18:5166-74.
22. Koike T, Ichikawa K, Atsumi T, Kasahara H, Matsuura E. Beta 2-glycoprotein I-anti-beta 2-glycoprotein I interaction. J Autoimmun 2000;15:97-100.
23. Brighton TA, Hogg PJ, Dai YP, Murray BH, Chong BH, Chesterman CN. Beta 2-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant. Br J Haematol 1996;93:185-94.
24. Manfredi AA, Rovere P, Heltai S et al. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum 1998;41:215-23.
25. Balasubramanian K, Schroit AJ. Characterization of phosphatidylserine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J Biol Chem 1998;273:29272-7.
26. Gharavi AE, Sammaritano LR, Wen J, Elkon KB. Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). J Clin Invest 1992;90:1105-9.
27. Pierangeli SS, Harris EN. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human beta 2 glycoprotein 1 or anticardiolipin antibodies alone. Clin Exp Immunol 1993;93:269-72.
28. Blank M, Faden D, Tincani A et al. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7:441-55.
29. Gharavi AE, Pierangeli SS, Espinola RG, Liu X, Colden Stanfield M, Harris EN. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 2002;46:545-52.
30. Blank M, Krause I, Fridkin M et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002; 109:797-804.
31. Amital H, Langevitz P, Levy Y et al. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: A clue to the origin of the disease. Clin Exp Rheumatol 1999;17:99-102.
32. Ziporen L, Goldberg I, Arad M et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: Immunopathologic findings in deformed heart valves. Lupus 1996;5:196-205.
33. Lev S, Shoenfeld Y. Cardiac valvulopathy in the antiphospholipid syndrome. Clin Rev Allergy Immunol 2002;23:341-8.
34. Cervera R. Recent advances in antiphospholipid antibody-related valvulopathies. J Autoimmun 2000;15:123-5.
35. Raschi E, Testoni C, Bosisio D et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003;101:3495-500.
36. Shapiro RF, Gamble CN, Wiesner KB et al. Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients. Ann Rheum Dis 1977; 36:508-16.
37. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus 2003;12:903-7.
38. Chapman J, Rand JH, Brey RL et al. Non-stroke neurological syndromes associated with antiphospholipid antibodies: Evaluation of clinical and experimental studies. Lupus 2003;12:514-7.
39. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999;42:1309-11.
40. Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci USA 1999;96:5164-8.
41. Adderson EE, Shikhman AR, Ward KE, Cunningham MW. Molecular analysis of polyreactive monoclonal antibodies from rheumatic carditis: Human anti-N-acetylglucosamine/anti-myosin antibody V region genes. J Immunol 1998;161:2020-31.
42. Arai T, Yoshida K, Kaburaki J et al. Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. Blood 2001;98:1889-96.
43. Hong DP, Hagihara Y, Kato H, Goto Y. Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands. Biochemistry 2001;40:8092-100.
44. Guilherme L, Cunha Neto E, Coelho V et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995;92:415-20.
45. Fae K, Kalil J, Toubert A, Guilherme L. Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol 2004;40:1129-35.
46. Amigo MC, Martinez Lavin M, Reyes PA. Acute rheumatic fever. Rheum Dis Clin North Am 1993;19:333-50.
47. Ayoub EM, Kaplan E. Host-parasite interaction in the pathogenesis of rheumatic fever. J Rheumatol Suppl 1991;30:6-13.
48. Badr Eldin MK. Solving the problem of the pathogenesis of rheumatic fever. Ann Trop Paediatr 1996;16:113-21.
49. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991;325:783-93.
50. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000;13:470-511.
51. Gibofsky A, Kerwar S, Zabriskie JB. Rheumatic fever. The relationships between host, microbe, and genetics. Rheum Dis Clin North Am 1998;24:237-59.
52. Blank M, Asherson RA, Cervera R, Shoenfeld Y. Antiphospholipid syndrome infectious origin. J Clin Immunol 2004;24:12-23.
53. Blank M, Shani A, Goldberg I et al. Libman-Sacks endocarditis associated with antiphospholipid syndrome and infection. Thromb Res 2004;114:589-92.
54. Ardiles L, Ramirez P, Moya P, Caorsi I, Mezzano S. Anticardiolipin antibodies in acute post-streptococcal glomerulonephritis and streptococcal impetigo. Nephron 1999;83:47-52.
55. Tamura N, Kobayashi S, Hashimoto H. Anticardiolipin antibodies in patients with post-streptococcal reactive arthritis. Ann Rheum Dis 2002;61: 374.
56. Cunningham MW, Swerlick RA. Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med 1986;164:998-1012.
57. Figueroa F, Berrios X, Gutierrez M et al. Anticardiolipin antibodies in acute rheumatic fever. J Rheumatol 1992;19:1175-80.
58. Ilarraza H, Marquez MF, Alcocer A, Banales JL, Nava AH, Reyes PA. Anticardiolipin antibodies are not associated with rheumatic heart disease. Lupus 2001;10:873-5.
59. Narin N, Kutukculer N, Narin F, Keser G, Doganavsargil E. Anticardiolipin antibodies in acute rheumatic fever and chronic rheumatic heart disease: Is there a significant association? Clin Exp Rheumatol 1996;14:567-9.
60. Diniz RE, Goldenberg J, Andrade LE et al. Antiphospholipid antibodies in rheumatic fever chorea. J Rheumatol 1994;21:1367-8.
61. Asherson RA, Hughes GR, Gledhill R, Quinn NP. Absence of antibodies to cardiolipin in patients with Huntington's chorea, Sydenhams chorea and acute rheumatic fever. J Neurol Neurosurg Psychiatry 1988;51: 1458.
62. Stollerman GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immunopathol 1991;61:131-42.
63. Roberts S, Kosanke S, Terrence Dunn S, Jankelow D, Duran CM, Cunningham MW. Pathogenic mechanisms in rheumatic carditis: Focus on valvular endothelium. J Infect Dis 2001;183:507-11.
64. Gharavi AE, Pierangeli SS, Colden Stanfield M, Liu XW, Espinola RG, Harris EN. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J Immunol 1999;163:2922-7.
65. George J, Blank M, Levy Y et al. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998; 97:900-6.
66. Del Papa N, Guidali L, Spatola L et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: Beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995;13:179-85.
67. Zhang J, McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 2005;105:1964-9.